DNB Fund - Biotechnology Retail A (EUR)
WKN A40FC7 | ISIN LU2814038266 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | CH0113817123 | Bellevue Biotech DT CHF | -3,39 % | +18,82 % | -0,31 |
|
| 2 | LU2026682919 | Candriam Equities L Biotechnology, V2 - Capitalisation | -4,23 % | +18,50 % | -0,36 |
|
| 3 | LU0942225912 | Candriam Equities L Biotechnology, R - Capitalisation | -4,45 % | +18,48 % | -0,37 |
|
| 4 | LU0317020203 | Candriam Equities L Biotechnology, V - Capitalisation | -4,54 % | +18,33 % | -0,38 |
|
| 5 | LU0133360163 | Candriam Equities L Biotechnology, I - Capitalisation | -4,64 % | +18,29 % | -0,38 |
|
| 73 | DE000DWS2UA1 | DWS ESG Biotech TFC | -12,43 % | +20,11 % | -0,74 |
|
| 74 | LU0959058974 | Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1 | -16,50 % | +19,62 % | -0,96 |
|
| 75 | LU1991432631 | UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse (SEK) P-acc, SEK | -16,05 % | +20,74 % | -0,89 |
|
| 76 | DE000A3DCA95 | BIT Biotech Opportunities S | -34,96 % | +30,36 % | -1,23 |
|
| 77 | DE000A3DCBA0 | BIT Biotech Opportunities I-II | -35,10 % | +30,34 % | -1,23 |
|